Conversely, normal liver enzyme levels (e.g., AST and ALT) do not guarantee the absence of NAFLD, non-alcoholic steatohepatitis (NASH), advanced cirrhosis, and fibrosis [27,30]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.